ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD
23.91
-1.6300
-6.38%
盘后:
23.91
0.0000
0.00%
17:30 EDT
成交量:
166.00万
成交额:
4,042.84万
市值:
17.05亿
市盈率:
-7.68
高:
25.50
开:
25.25
低:
23.89
收:
25.54
52周最高:
94.90
52周最低:
23.89
股本:
7,130.99万
流通股本:
5,546.30万
量比:
1.41
换手率:
2.99%
股息:
- -
股息率:
- -
每股收益(TTM):
-3.1128
每股收益(LYR):
-2.3852
净资产收益率:
-20.21%
总资产收益率:
-14.95%
市净率:
1.26
市盈率(LYR):
-10.02
数据加载中...
总览
公司
新闻资讯
公告
数据简报-随着竞争日趋激烈,减肥药开发商纷纷抢占这一利润丰厚的市场
路透中文
·
09/22
杰富瑞表示,随着投资者等待更多肥胖症临床试验数据,Structure股价下跌
路透中文
·
09/09
Structure Therapeutics旗下Aleniglipron在Access Ole试验中展现72周最高16.2%体重降幅
美股速递
·
09/08
Structure Therapeutics候选药物Accg-2671展现约6天半衰期,未出现严重不良事件,1/2a期SAD试验中实现3.3%体重下降
美股速递
·
09/08
Structure Therapeutics宣布ACCG-2671在12周MAD 1/2a期试验完成首批受试者给药,顶线数据预计2027年上半年公布
美股速递
·
09/08
Structure Therapeutics公布口服小分子Amylin与GLP-1项目在慢性体重管理中的积极临床数据
美股速递
·
09/08
新闻稿:Septerna任命资深行业专家Rajiv Patni医学博士担任首席医疗官
投资观察
·
08/25
数据简报-随着小型企业不断涌现,减肥药的上市竞争日益白热化
路透中文
·
07/08
晶泰控股(02228)与国际知名药企达成超4亿美元AI药物发现战略合作 攻坚GPCR靶点口服新药
智通财经
·
06/09
Structure实验性减肥药未显示肝损伤迹象
路透中文
·
06/06
Structure Therapeutics宣布,Aleniglipron在2B期试验中显示出长达36周以上最高达16.2%的减重效果
美股速递
·
06/06
Structure Therapeutics旗下阿伦利普隆展现良好耐受性,停药率仅为10.4%
美股速递
·
06/06
Structure Therapeutics修订并重述与Leerink Partners及Cantor Fitzgerald的销售协议
美股速递
·
05/08
Structure Therapeutics将ATM增发规模扩大1.5亿美元 总额达4亿美元
美股速递
·
05/08
埃诺格鲁肽注射液全国首批处方落地
经济参考网
·
04/27
Structure Therapeutics任命Matthew Lang为首席运营官兼总法律顾问
投资观察
·
04/15
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/GPCR/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GPCR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GPCR\",,,,,undefined,":{"symbol":"GPCR","market":"US","secType":"STK","nameCN":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","latestPrice":23.91,"timestamp":1791835200000,"preClose":25.54,"halted":0,"volume":1660040,"hourTrading":{"tag":"盘后","latestPrice":23.91,"preClose":23.91,"latestTime":"17:30 EDT","volume":36737,"amount":878545.1496499999,"timestamp":1791840611932,"change":0,"changeRate":0,"amplitude":0.019657},"delay":0,"changeRate":-0.06382145653876269,"floatShares":55463000,"shares":71309857,"eps":-3.1128,"marketStatus":"盘后交易","change":-1.63,"latestTime":"10-12 17:32:15 EDT","open":25.25,"high":25.5,"low":23.89,"amount":40428414.9552,"amplitude":0.063038,"askPrice":24.38,"askSize":62,"bidPrice":23.91,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.1128,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791849600000},"marketStatusCode":4,"adr":0,"adrRate":3,"listingDate":1675400400000,"exchange":"NASDAQ","adjPreClose":25.54,"preHourTrading":{"tag":"盘前","latestPrice":25.18,"preClose":25.54,"latestTime":"09:29 EDT","volume":605,"amount":16068.855055,"timestamp":1791811741004,"change":-0.36,"changeRate":-0.014096,"amplitude":0.057557},"postHourTrading":{"tag":"盘后","latestPrice":23.91,"preClose":23.91,"latestTime":"17:30 EDT","volume":36737,"amount":878545.1496499999,"timestamp":1791840611932,"change":0,"changeRate":0,"amplitude":0.019657},"volumeRatio":1.413475,"impliedVol":0.8318,"impliedVolPercentile":0.6056},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GPCR\",,,,,undefined,":{"symbol":"GPCR","floatShares":55463000,"roa":"-14.95%","roe":"-20.21%","lyrEps":-2.385222,"volumeRatio":1.413475,"shares":71309857,"dividePrice":0,"high":25.5,"amplitude":0.063038,"preClose":25.54,"low":23.89,"week52Low":23.89,"pbRate":"1.26","week52High":94.9,"institutionHeld":0,"latestPrice":23.91,"committee":0.234568,"eps":-3.1128,"divideRate":0,"volume":1660040,"delay":0,"ttmEps":-3.1128,"open":25.25,"prevYearClose":69.55,"prevWeekClose":25.54,"prevMonthClose":31.27,"prevQuarterClose":31.27,"fiveDayClose":27.59,"twentyDayClose":38.44,"sixtyDayClose":48.48},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GPCR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"GPCR","fiscalQuarterEnding":"2026/06","expectedEps":-0.39,"name":null,"time":"盘后","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2026-05-07","symbol":"GPCR","fiscalQuarterEnding":"2026/03","expectedEps":-0.39,"name":null,"time":"盘后","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.35},{"market":"US","date":"2026-02-26","symbol":"GPCR","fiscalQuarterEnding":"2025/12","expectedEps":-0.35,"name":null,"time":"盘后","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2025-11-06","symbol":"GPCR","fiscalQuarterEnding":"2025/09","expectedEps":-0.36,"name":null,"time":"盘后","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.37},{"market":"US","date":"2025-08-06","symbol":"GPCR","fiscalQuarterEnding":"2025/06","expectedEps":-0.28,"name":null,"time":"盘后","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.36}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GPCR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GPCR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3529,"buy":0.5882,"hold":0.0588,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5882,"analysts":17,"updateTime":1777348800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GPCR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GPCR","date":"2026-10-09","current":-7.681187,"percent":0.908889,"low":-50.180001,"twenty":-24.083644,"median":-19.313395,"eighty":-10.562885,"high":-5.211405,"avg":-19.184569,"sd":8.200734,"marketCap":1830524029},"quantilePoints":[{"date":"2023-02-03","current":-25.001825,"twenty":-43.272389,"median":-43.272389,"eighty":-32.310051,"marketCap":951294422},{"date":"2023-02-10","current":-22.116999,"twenty":-35.964163,"median":-23.496907,"eighty":-22.21316,"marketCap":841529681},{"date":"2023-02-17","current":-21.285207,"twenty":-24.521021,"median":-22.645883,"eighty":-21.915061,"marketCap":809880847},{"date":"2023-02-24","current":-23.36709,"twenty":-23.715192,"median":-22.645883,"eighty":-21.847749,"marketCap":889094402},{"date":"2023-03-03","current":-25.530709,"twenty":-24.422936,"median":-22.718004,"eighty":-21.972757,"marketCap":971417957},{"date":"2023-03-10","current":-22.636267,"twenty":-24.85566,"median":-22.790125,"eighty":-22.063149,"marketCap":861287334},{"date":"2023-03-17","current":-22.232392,"twenty":-24.422936,"median":-22.70358,"eighty":-22.09392,"marketCap":845920270},{"date":"2023-03-24","current":-21.876596,"twenty":-23.762311,"median":-22.568955,"eighty":-21.891982,"marketCap":832382619},{"date":"2023-03-31","current":-16.960589,"twenty":-23.565181,"median":-22.314128,"eighty":-21.634271,"marketCap":870434396},{"date":"2023-04-06","current":-17.823234,"twenty":-23.376706,"median":-22.232392,"eighty":-21.285207,"marketCap":914706175},{"date":"2023-04-14","current":-17.473898,"twenty":-23.36709,"median":-22.116999,"eighty":-18.643102,"marketCap":896777933},{"date":"2023-04-21","current":-17.210114,"twenty":-23.194,"median":-22.059302,"eighty":-17.623613,"marketCap":883240282},{"date":"2023-04-28","current":-17.815518,"twenty":-23.078607,"median":-21.876596,"eighty":-17.586227,"marketCap":914310203},{"date":"2023-05-05","current":-17.709107,"twenty":-22.982446,"median":-21.689083,"eighty":-17.623613,"marketCap":908849077},{"date":"2023-05-12","current":-17.00755,"twenty":-22.790125,"median":-21.491953,"eighty":-17.586227,"marketCap":956079400},{"date":"2023-05-19","current":-15.32957,"twenty":-22.780509,"median":-20.818827,"eighty":-17.473898,"marketCap":861751761},{"date":"2023-05-26","current":-19.808636,"twenty":-22.761276,"median":-19.808636,"eighty":-17.466769,"marketCap":1113542462},{"date":"2023-06-02","current":-21.830342,"twenty":-22.668962,"median":-20.674586,"eighty":-17.472472,"marketCap":1227192672},{"date":"2023-06-09","current":-23.110075,"twenty":-22.668962,"median":-21.38858,"eighty":-17.563702,"marketCap":1299132872},{"date":"2023-06-16","current":-21.061141,"twenty":-22.668962,"median":-21.491953,"eighty":-17.586212,"marketCap":1183952020},{"date":"2023-06-23","current":-21.782692,"twenty":-22.640113,"median":-21.568882,"eighty":-17.608538,"marketCap":1224514048},{"date":"2023-06-30","current":-27.561913,"twenty":-22.772816,"median":-21.571672,"eighty":-17.623492,"marketCap":1549392931},{"date":"2023-07-07","current":-24.451072,"twenty":-23.059375,"median":-21.612515,"eighty":-17.625039,"marketCap":1374517018},{"date":"2023-07-14","current":-21.428724,"twenty":-23.103781,"median":-21.707815,"eighty":-17.644282,"marketCap":1204615694},{"date":"2023-07-21","current":-23.069233,"twenty":-23.103781,"median":-21.780436,"eighty":-17.700571,"marketCap":1296836908},{"date":"2023-07-28","current":-23.552536,"twenty":-23.333385,"median":-21.782692,"eighty":-17.727736,"marketCap":1324005814},{"date":"2023-08-04","current":-21.592094,"twenty":-23.51737,"median":-21.782692,"eighty":-17.804907,"marketCap":1213799550},{"date":"2023-08-11","current":-19.978813,"twenty":-23.374783,"median":-21.781564,"eighty":-17.817061,"marketCap":1123108978},{"date":"2023-08-18","current":-16.072919,"twenty":-23.333385,"median":-21.735043,"eighty":-17.644282,"marketCap":1053531639},{"date":"2023-08-25","current":-16.66259,"twenty":-23.197654,"median":-21.646551,"eighty":-17.586168,"marketCap":1092182818},{"date":"2023-09-01","current":-16.458249,"twenty":-23.185384,"median":-21.592094,"eighty":-17.468195,"marketCap":1078788845},{"date":"2023-09-08","current":-16.680105,"twenty":-23.150918,"median":-21.568882,"eighty":-17.319402,"marketCap":1093330873},{"date":"2023-09-15","current":-18.326514,"twenty":-23.110075,"median":-21.460338,"eighty":-17.211393,"marketCap":1201248026},{"date":"2023-09-22","current":-19.937893,"twenty":-23.078607,"median":-21.067948,"eighty":-17.309925,"marketCap":1306869070},{"date":"2023-09-29","current":-21.876218,"twenty":-23.069233,"median":-21.012104,"eighty":-17.319402,"marketCap":1433920470},{"date":"2023-10-06","current":-37.165618,"twenty":-23.194,"median":-21.285207,"eighty":-17.395476,"marketCap":2436094784},{"date":"2023-10-13","current":-44.162453,"twenty":-23.552536,"median":-21.525005,"eighty":-17.459473,"marketCap":2894716299},{"date":"2023-10-20","current":-45.222784,"twenty":-23.852048,"median":-21.571672,"eighty":-17.466769,"marketCap":2964217822},{"date":"2023-10-27","current":-47.275909,"twenty":-23.892891,"median":-21.592094,"eighty":-17.469621,"marketCap":3098794020},{"date":"2023-11-03","current":-48.538851,"twenty":-24.328544,"median":-21.646551,"eighty":-17.490333,"marketCap":3181576088},{"date":"2023-11-10","current":-38.273225,"twenty":-24.864943,"median":-21.735043,"eighty":-17.514986,"marketCap":2508695101},{"date":"2023-11-17","current":-27.570058,"twenty":-25.04304,"median":-21.781564,"eighty":-17.543453,"marketCap":2122673903},{"date":"2023-11-24","current":-32.691508,"twenty":-27.365869,"median":-21.782692,"eighty":-17.586168,"marketCap":2516984612},{"date":"2023-12-01","current":-35.337541,"twenty":-28.3175,"median":-21.830342,"eighty":-17.593664,"marketCap":2720707940},{"date":"2023-12-08","current":-37.983573,"twenty":-33.138225,"median":-21.904522,"eighty":-17.623452,"marketCap":2924431267},{"date":"2023-12-15","current":-37.177707,"twenty":-34.105722,"median":-22.049686,"eighty":-17.625039,"marketCap":2862386033},{"date":"2023-12-22","current":-20.939825,"twenty":-34.105722,"median":-22.001606,"eighty":-17.644282,"marketCap":1612198995},{"date":"2023-12-29","current":-23.446258,"twenty":-34.065552,"median":-22.068918,"eighty":-17.684898,"marketCap":1805174329},{"date":"2024-01-05","current":-26.187472,"twenty":-34.000259,"median":-22.102574,"eighty":-17.702705,"marketCap":2016225834},{"date":"2024-01-12","current":-28.789086,"twenty":-33.67371,"median":-22.232392,"eighty":-17.746366,"marketCap":2216529345},{"date":"2024-01-19","current":-27.710368,"twenty":-33.290514,"median":-22.259189,"eighty":-17.804907,"marketCap":2133476670},{"date":"2024-01-26","current":-26.745867,"twenty":-33.138225,"median":-22.283013,"eighty":-17.817061,"marketCap":2059217807},{"date":"2024-02-02","current":-28.598724,"twenty":-32.691508,"median":-22.44298,"eighty":-17.823234,"marketCap":2201872991},{"date":"2024-02-09","current":-29.823387,"twenty":-32.667396,"median":-22.576119,"eighty":-17.835432,"marketCap":2296162205},{"date":"2024-02-16","current":-28.427399,"twenty":-32.293017,"median":-22.636267,"eighty":-17.890184,"marketCap":2188682272},{"date":"2024-02-23","current":-26.035182,"twenty":-31.181303,"median":-22.647193,"eighty":-17.91403,"marketCap":2004500750},{"date":"2024-03-01","current":-25.743294,"twenty":-31.092467,"median":-22.775115,"eighty":-17.959972,"marketCap":1982027673},{"date":"2024-03-08","current":-22.849791,"twenty":-30.933832,"median":-22.849791,"eighty":-18.031985,"marketCap":1759251085},{"date":"2024-03-15","current":-18.291889,"twenty":-29.823387,"median":-22.775115,"eighty":-18.031985,"marketCap":1639319082},{"date":"2024-03-22","current":-22.815466,"twenty":-29.601298,"median":-22.761276,"eighty":-18.070517,"marketCap":2044722039},{"date":"2024-03-28","current":-22.311113,"twenty":-29.398245,"median":-22.645883,"eighty":-18.070517,"marketCap":1999521939},{"date":"2024-04-05","current":-20.434088,"twenty":-29.301795,"median":-22.601624,"eighty":-18.089549,"marketCap":1831303011},{"date":"2024-04-12","current":-20.928042,"twenty":-29.107626,"median":-22.568955,"eighty":-18.098906,"marketCap":1875571150},{"date":"2024-04-19","current":-18.81184,"twenty":-29.061939,"median":-22.455039,"eighty":-18.224405,"marketCap":1685917123},{"date":"2024-04-26","current":-20.267704,"twenty":-28.863962,"median":-22.311113,"eighty":-18.256547,"marketCap":1816391638},{"date":"2024-05-03","current":-20.281918,"twenty":-28.794162,"median":-22.289169,"eighty":-18.270537,"marketCap":1817665530},{"date":"2024-05-10","current":-20.105056,"twenty":-28.789086,"median":-22.270856,"eighty":-18.288305,"marketCap":1801815151},{"date":"2024-05-17","current":-17.123915,"twenty":-28.636796,"median":-22.232392,"eighty":-18.098906,"marketCap":1672681180},{"date":"2024-05-24","current":-18.288418,"twenty":-28.476893,"median":-22.116999,"eighty":-18.062811,"marketCap":1786430959},{"date":"2024-05-31","current":-16.11295,"twenty":-28.435013,"median":-22.068918,"eighty":-17.902107,"marketCap":1573929112},{"date":"2024-06-07","current":-26.55105,"twenty":-28.381712,"median":-22.102574,"eighty":-17.902107,"marketCap":2593533072},{"date":"2024-06-14","current":-24.646705,"twenty":-28.337752,"median":-22.198735,"eighty":-17.932407,"marketCap":2407514791},{"date":"2024-06-21","current":-22.312809,"twenty":-28.3175,"median":-22.24579,"eighty":-17.974375,"marketCap":2179537500},{"date":"2024-06-28","current":-18.680713,"twenty":-28.3175,"median":-22.24579,"eighty":-18.00318,"marketCap":1824750754},{"date":"2024-07-05","current":-17.874111,"twenty":-28.267548,"median":-22.198735,"eighty":-17.932407,"marketCap":1745961056},{"date":"2024-07-12","current":-20.408464,"twenty":-28.068249,"median":-22.08815,"eighty":-17.932407,"marketCap":1993519219},{"date":"2024-07-15","current":-20.943017,"twenty":-28.006064,"median":-22.078534,"eighty":-17.941595,"marketCap":2045734877},{"date":"2024-08-02","current":-17.387286,"twenty":-27.943879,"median":-22.068918,"eighty":-17.908069,"marketCap":1698407510},{"date":"2024-08-09","current":-16.461364,"twenty":-27.802578,"median":-21.942986,"eighty":-17.823234,"marketCap":1607962532},{"date":"2024-08-16","current":-20.792004,"twenty":-27.780694,"median":-21.876596,"eighty":-17.821691,"marketCap":2088244945},{"date":"2024-08-23","current":-22.295452,"twenty":-27.74971,"median":-21.929398,"eighty":-17.823234,"marketCap":2239243758},{"date":"2024-08-30","current":-21.822777,"twenty":-27.716713,"median":-21.953525,"eighty":-17.863936,"marketCap":2191770646},{"date":"2024-09-06","current":-21.851252,"twenty":-27.691332,"median":-21.926349,"eighty":-17.874111,"marketCap":2194630472},{"date":"2024-09-13","current":-22.944669,"twenty":-27.671026,"median":-21.901472,"eighty":-17.880178,"marketCap":2304447790},{"date":"2024-09-20","current":-22.067657,"twenty":-27.608415,"median":-21.926349,"eighty":-17.902107,"marketCap":2216365150},{"date":"2024-09-27","current":-23.650834,"twenty":-27.565171,"median":-22.001606,"eighty":-17.941595,"marketCap":2375371475},{"date":"2024-10-04","current":-24.083644,"twenty":-27.536769,"median":-22.068918,"eighty":-18.000093,"marketCap":2418840830},{"date":"2024-10-11","current":-22.130301,"twenty":-27.481934,"median":-22.12365,"eighty":-18.029927,"marketCap":2222656767},{"date":"2024-10-18","current":-22.563112,"twenty":-27.163394,"median":-22.116999,"eighty":-18.055104,"marketCap":2266126122},{"date":"2024-10-25","current":-21.333018,"twenty":-26.967956,"median":-22.11226,"eighty":-18.070517,"marketCap":2142581639},{"date":"2024-10-31","current":-21.560813,"twenty":-26.932422,"median":-22.097835,"eighty":-18.080033,"marketCap":2165460247},{"date":"2024-11-08","current":-21.839862,"twenty":-26.875803,"median":-22.107521,"eighty":-18.096607,"marketCap":2193486542},{"date":"2024-11-15","current":-19.500107,"twenty":-26.820843,"median":-22.068288,"eighty":-18.16223,"marketCap":2155736838},{"date":"2024-11-22","current":-15.573182,"twenty":-26.740791,"median":-22.039183,"eighty":-18.047398,"marketCap":1721615252},{"date":"2024-11-29","current":-17.170432,"twenty":-26.702879,"median":-21.932448,"eighty":-17.923218,"marketCap":1898191276},{"date":"2024-12-06","current":-16.181125,"twenty":-26.575564,"median":-21.883856,"eighty":-17.833409,"marketCap":1788823393},{"date":"2024-12-13","current":-16.424567,"twenty":-26.524021,"median":-21.851252,"eighty":-17.817061,"marketCap":1815735909},{"date":"2024-12-20","current":-15.523314,"twenty":-26.386717,"median":-21.835102,"eighty":-17.715324,"marketCap":1716102339},{"date":"2024-12-27","current":-15.30059,"twenty":-26.269962,"median":-21.822777,"eighty":-17.687076,"marketCap":1691480250},{"date":"2025-01-03","current":-14.601342,"twenty":-26.20397,"median":-21.78933,"eighty":-17.625803,"marketCap":1614178343},{"date":"2025-01-10","current":-14.005686,"twenty":-26.17605,"median":-21.782692,"eighty":-17.604018,"marketCap":1548328570},{"date":"2025-01-17","current":-13.974608,"twenty":-26.160821,"median":-21.780436,"eighty":-17.514986,"marketCap":1544892930},{"date":"2025-01-24","current":-14.482211,"twenty":-26.10752,"median":-21.737354,"eighty":-17.469621,"marketCap":1601008389},{"date":"2025-01-31","current":-15.7046,"twenty":-26.035182,"median":-21.700984,"eighty":-17.381485,"marketCap":1736143575},{"date":"2025-02-07","current":-15.549212,"twenty":-26.032644,"median":-21.680405,"eighty":-17.295679,"marketCap":1718965373},{"date":"2025-02-14","current":-12.622728,"twenty":-25.9819,"median":-21.605123,"eighty":-17.234446,"marketCap":1395442576},{"date":"2025-02-21","current":-12.115125,"twenty":-25.903236,"median":-21.581883,"eighty":-17.21037,"marketCap":1339327118},{"date":"2025-02-28","current":-11.819887,"twenty":-25.84482,"median":-21.567582,"eighty":-17.171628,"marketCap":1306688535},{"date":"2025-03-07","current":-11.01217,"twenty":-25.735679,"median":-21.559435,"eighty":-17.124089,"marketCap":1349277189},{"date":"2025-03-14","current":-9.547313,"twenty":-25.689992,"median":-21.491953,"eighty":-17.045645,"marketCap":1169794078},{"date":"2025-03-21","current":-10.235281,"twenty":-25.609403,"median":-21.417887,"eighty":-16.960589,"marketCap":1254088063},{"date":"2025-03-28","current":-9.33203,"twenty":-25.527539,"median":-21.321628,"eighty":-16.93886,"marketCap":1143416369},{"date":"2025-04-04","current":-7.64253,"twenty":-25.480594,"median":-21.202701,"eighty":-16.831205,"marketCap":936408691},{"date":"2025-04-11","current":-7.043483,"twenty":-25.340669,"median":-21.061141,"eighty":-16.666093,"marketCap":863009847},{"date":"2025-04-17","current":-8.672143,"twenty":-25.329214,"median":-21.042579,"eighty":-16.563339,"marketCap":1062562954},{"date":"2025-04-25","current":-11.068331,"twenty":-25.25285,"median":-20.951128,"eighty":-16.426861,"marketCap":1356158331},{"date":"2025-05-02","current":-12.790591,"twenty":-25.171712,"median":-20.933479,"eighty":-16.305436,"marketCap":1567180008},{"date":"2025-05-09","current":-12.551909,"twenty":-25.070517,"median":-20.891345,"eighty":-16.181125,"marketCap":1537935156},{"date":"2025-05-16","current":-9.774326,"twenty":-25.068859,"median":-20.829252,"eighty":-16.056814,"marketCap":1400885752},{"date":"2025-05-23","current":-9.895696,"twenty":-25.0453,"median":-20.693431,"eighty":-15.839386,"marketCap":1418280862},{"date":"2025-05-30","current":-9.000467,"twenty":-25.01052,"median":-20.672234,"eighty":-15.745511,"marketCap":1289973912},{"date":"2025-06-06","current":-8.619091,"twenty":-25.001825,"median":-20.550917,"eighty":-15.544032,"marketCap":1235314001},{"date":"2025-06-13","current":-8.920177,"twenty":-24.996225,"median":-20.487391,"eighty":-15.387426,"marketCap":1278466562},{"date":"2025-06-20","current":-8.679308,"twenty":-24.952868,"median":-20.449033,"eighty":-14.973238,"marketCap":1243944513},{"date":"2025-06-27","current":-8.462526,"twenty":-24.918331,"median":-20.434088,"eighty":-14.66039,"marketCap":1212874668},{"date":"2025-07-03","current":-8.175491,"twenty":-24.875783,"median":-20.408464,"eighty":-14.607558,"marketCap":1171735893},{"date":"2025-07-11","current":-7.587369,"twenty":-24.818526,"median":-20.385744,"eighty":-14.451133,"marketCap":1087444556},{"date":"2025-07-18","current":-7.840282,"twenty":-24.807686,"median":-20.281918,"eighty":-14.123781,"marketCap":1123692707},{"date":"2025-07-25","current":-7.334457,"twenty":-24.781668,"median":-20.180483,"eighty":-13.987039,"marketCap":1051196404},{"date":"2025-08-01","current":-7.145777,"twenty":-24.722332,"median":-20.085721,"eighty":-13.108576,"marketCap":1024154132},{"date":"2025-08-08","current":-5.211405,"twenty":-24.651853,"median":-19.971704,"eighty":-12.812535,"marketCap":932580977},{"date":"2025-08-15","current":-5.964179,"twenty":-24.61951,"median":-19.937893,"eighty":-12.626872,"marketCap":1067289809},{"date":"2025-08-22","current":-6.234546,"twenty":-24.540145,"median":-19.829477,"eighty":-12.490132,"marketCap":1115672078},{"date":"2025-08-29","current":-6.160517,"twenty":-24.4698,"median":-19.66456,"eighty":-12.119485,"marketCap":1102424552},{"date":"2025-09-05","current":-6.360074,"twenty":-24.389808,"median":-19.576169,"eighty":-11.77845,"marketCap":1138135274},{"date":"2025-09-12","current":-6.720564,"twenty":-24.139365,"median":-19.456275,"eighty":-11.057099,"marketCap":1202644966},{"date":"2025-09-19","current":-7.47695,"twenty":-24.11098,"median":-19.134734,"eighty":-10.896967,"marketCap":1338000122},{"date":"2025-09-26","current":-8.043434,"twenty":-24.072254,"median":-19.014985,"eighty":-10.567565,"marketCap":1439372495},{"date":"2025-10-03","current":-8.568076,"twenty":-24.020356,"median":-18.941828,"eighty":-10.325716,"marketCap":1533257136},{"date":"2025-10-10","current":-9.833009,"twenty":-23.986828,"median":-18.81071,"eighty":-10.186609,"marketCap":1759617036},{"date":"2025-10-17","current":-8.87063,"twenty":-23.947347,"median":-18.74276,"eighty":-9.917033,"marketCap":1587399198},{"date":"2025-10-24","current":-8.548764,"twenty":-23.914099,"median":-18.661907,"eighty":-9.852324,"marketCap":1529801259},{"date":"2025-10-31","current":-10.370526,"twenty":-23.886602,"median":-18.351918,"eighty":-9.836476,"marketCap":1855805594},{"date":"2025-11-07","current":-10.772858,"twenty":-23.868757,"median":-18.327399,"eighty":-9.850579,"marketCap":1927803018},{"date":"2025-11-14","current":-10.08006,"twenty":-23.852048,"median":-18.288418,"eighty":-9.817863,"marketCap":2123717400},{"date":"2025-11-21","current":-9.889979,"twenty":-23.841601,"median":-18.256152,"eighty":-9.836476,"marketCap":2083670157},{"date":"2025-11-28","current":-10.313341,"twenty":-23.799814,"median":-18.097181,"eighty":-9.841018,"marketCap":2172866288},{"date":"2025-12-05","current":-9.460856,"twenty":-23.776121,"median":-18.070517,"eighty":-9.814076,"marketCap":1993260474},{"date":"2025-12-12","current":-19.422835,"twenty":-23.650834,"median":-18.082412,"eighty":-9.833009,"marketCap":4092100041},{"date":"2025-12-19","current":-17.985707,"twenty":-23.62393,"median":-18.070517,"eighty":-9.841018,"marketCap":3789318618},{"date":"2025-12-26","current":-22.869735,"twenty":-23.621272,"median":-18.100056,"eighty":-9.848479,"marketCap":4818310220},{"date":"2026-01-02","current":-22.823793,"twenty":-23.615623,"median":-18.255492,"eighty":-9.851048,"marketCap":4808630734},{"date":"2026-01-09","current":-21.980412,"twenty":-23.576442,"median":-18.281194,"eighty":-9.851517,"marketCap":4630943013},{"date":"2026-01-16","current":-27.900487,"twenty":-23.621936,"median":-18.326514,"eighty":-9.853937,"marketCap":5878214018},{"date":"2026-01-23","current":-30.148409,"twenty":-23.790337,"median":-18.349084,"eighty":-9.86147,"marketCap":6351817477},{"date":"2026-01-30","current":-28.599475,"twenty":-23.883185,"median":-18.63625,"eighty":-9.874048,"marketCap":6025480495},{"date":"2026-02-06","current":-24.024872,"twenty":-24.012922,"median":-18.680713,"eighty":-9.881446,"marketCap":5061680173},{"date":"2026-02-13","current":-23.64092,"twenty":-24.104146,"median":-18.735704,"eighty":-9.886523,"marketCap":4980787319},{"date":"2026-02-20","current":-22.141212,"twenty":-24.072254,"median":-18.787312,"eighty":-9.891122,"marketCap":4664821216},{"date":"2026-02-27","current":-21.248606,"twenty":-24.026331,"median":-18.905431,"eighty":-9.903769,"marketCap":4476762617},{"date":"2026-03-06","current":-29.951815,"twenty":-24.389808,"median":-18.958825,"eighty":-9.939515,"marketCap":4229256176},{"date":"2026-03-13","current":-27.383083,"twenty":-24.63457,"median":-19.091174,"eighty":-9.953915,"marketCap":3866546098},{"date":"2026-03-20","current":-25.316057,"twenty":-24.813106,"median":-19.247915,"eighty":-9.965451,"marketCap":3574677833},{"date":"2026-03-27","current":-23.178791,"twenty":-24.786548,"median":-19.412443,"eighty":-10.00684,"marketCap":3272891714},{"date":"2026-04-02","current":-25.170562,"twenty":-24.791427,"median":-19.500107,"eighty":-10.024679,"marketCap":3554133708},{"date":"2026-04-10","current":-27.664038,"twenty":-24.924896,"median":-19.588971,"eighty":-10.070397,"marketCap":3906217513},{"date":"2026-04-17","current":-26.841241,"twenty":-25.001825,"median":-19.762743,"eighty":-10.08006,"marketCap":3790036942},{"date":"2026-04-24","current":-23.59019,"twenty":-25.001825,"median":-19.852578,"eighty":-10.16646,"marketCap":3330982000},{"date":"2026-05-01","current":-20.863024,"twenty":-25.001825,"median":-19.937893,"eighty":-10.183801,"marketCap":2945900742},{"date":"2026-05-08","current":-19.705365,"twenty":-24.994825,"median":-19.961493,"eighty":-10.197841,"marketCap":2782437010},{"date":"2026-05-15","current":-16.62279,"twenty":-24.933886,"median":-19.910742,"eighty":-10.230435,"marketCap":2831476129},{"date":"2026-05-22","current":-16.184689,"twenty":-24.924896,"median":-19.829477,"eighty":-10.235281,"marketCap":2756851382},{"date":"2026-05-29","current":-20.218762,"twenty":-24.916142,"median":-19.78569,"eighty":-10.28472,"marketCap":2854929621},{"date":"2026-06-05","current":-19.660066,"twenty":-24.837612,"median":-19.705365,"eighty":-10.310089,"marketCap":2776040603},{"date":"2026-06-12","current":-21.794185,"twenty":-24.818526,"median":-19.734054,"eighty":-10.313341,"marketCap":3077382440},{"date":"2026-06-18","current":-18.776621,"twenty":-24.802267,"median":-19.684963,"eighty":-10.332349,"marketCap":3198353220},{"date":"2026-06-26","current":-20.13271,"twenty":-24.776789,"median":-19.66456,"eighty":-10.358393,"marketCap":3429345397},{"date":"2026-07-02","current":-21.747499,"twenty":-24.722332,"median":-19.762743,"eighty":-10.368595,"marketCap":3704403773},{"date":"2026-07-10","current":-23.007619,"twenty":-24.651853,"median":-19.829477,"eighty":-10.39842,"marketCap":3919048812},{"date":"2026-07-17","current":-19.206397,"twenty":-24.633491,"median":-19.854838,"eighty":-10.468301,"marketCap":3271559971},{"date":"2026-07-24","current":-21.196718,"twenty":-24.602614,"median":-19.924318,"eighty":-10.512193,"marketCap":3610585412},{"date":"2026-07-31","current":-20.641765,"twenty":-24.584569,"median":-19.948142,"eighty":-10.52082,"marketCap":3516056306},{"date":"2026-08-07","current":-21.956128,"twenty":-24.559431,"median":-19.978813,"eighty":-10.545017,"marketCap":3739941031},{"date":"2026-08-14","current":-18.156488,"twenty":-24.476043,"median":-19.948142,"eighty":-10.550775,"marketCap":3900649177},{"date":"2026-08-21","current":-16.769027,"twenty":-24.436431,"median":-19.854838,"eighty":-10.567565,"marketCap":3602573975},{"date":"2026-08-28","current":-16.33752,"twenty":-24.340741,"median":-19.804817,"eighty":-10.589873,"marketCap":3509871161},{"date":"2026-09-04","current":-15.713495,"twenty":-24.190229,"median":-19.757177,"eighty":-10.628294,"marketCap":3375808630},{"date":"2026-09-11","current":-13.127772,"twenty":-24.182202,"median":-19.66456,"eighty":-10.724579,"marketCap":2820304844},{"date":"2026-09-18","current":-11.65069,"twenty":-24.147083,"median":-19.602283,"eighty":-10.772858,"marketCap":2502975980},{"date":"2026-09-25","current":-11.956064,"twenty":-24.144753,"median":-19.544826,"eighty":-10.782784,"marketCap":2568581049},{"date":"2026-10-02","current":-9.619288,"twenty":-24.117814,"median":-19.417639,"eighty":-10.772858,"marketCap":2066559655},{"date":"2026-10-09","current":-8.520604,"twenty":-24.083644,"median":-19.313395,"eighty":-10.562885,"marketCap":1830524029}],"updateTime":1791838842269},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GPCR\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669142742","title":"数据简报-随着竞争日趋激烈,减肥药开发商纷纷抢占这一利润丰厚的市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142742","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142742?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 21:09","pubTimestamp":1790082578,"startTime":"0","endTime":"0","summary":"数据简报-随着竞争日趋激烈,减肥药开发商纷纷抢占这一利润丰厚的市场更新发稿日期,补充罗氏和Viking Therapeutics提供的最新减肥药临床试验数据路透9月22日-减肥药市场正蓬勃发展,生物技术公司竞相争夺这一由诺和诺德和礼来主导的快速增长领域的市场份额。在其中一项试验中,该药物帮助超重患者减重22.7%,低于诺和诺德25%的预期。辉瑞表示,其目标是在2028年获得快速增长的减肥药市场中的首次批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4S45E0UX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PAWZ","IBBQ","LLYZ","ELIL","GDOC","BIB","AMGN","IBRN","KLRA","SRRK","ALT","VHT","WDNA","00016","GPCR","OZEM","HRTS","FHLC","THNR","01093","03692","03145","OPK","TRUH","FTXH","PFE","KURE","AZN.UK","LLYX","IBB","80016","PPH","TBXU","MEDX","CURE","JDOC","CANC","LLII","LLY","MRK","VKTX","SUHJY","03933","IXJ","BBH","MTSR","03121","02105","AGNG","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372108","title":"杰富瑞表示,随着投资者等待更多肥胖症临床试验数据,Structure股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372108","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372108?lang=zh_cn&edition=fundamental","pubTime":"2026-09-09 03:48","pubTimestamp":1788896882,"startTime":"0","endTime":"0","summary":"BUZZ-杰富瑞表示,随着投资者等待更多肥胖症临床试验数据,Structure股价下跌9月8日-** Structure Therapeutics(GPCR.O)股价下跌13.4%,至40.73美元** 杰富瑞(Jefferies)表示,Structure公布试验数据后股价走弱与数据集本身无关,无论是试验结果还是公开电话会议中均未出现任何基本面问题** 当日早些时候,Structure公布了其实验","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4S4501KF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","GPCR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165843596","title":"Structure Therapeutics旗下Aleniglipron在Access Ole试验中展现72周最高16.2%体重降幅","url":"https://stock-news.laohu8.com/highlight/detail?id=1165843596","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165843596?lang=zh_cn&edition=fundamental","pubTime":"2026-09-08 20:03","pubTimestamp":1788868999,"startTime":"0","endTime":"0","summary":"Structure Therapeutics宣布,其候选药物Aleniglipron在Access Ole临床试验中取得了令人瞩目的成果——患者在72周的治疗周期内,体重减轻幅度最高达到16.2%。这一数据标志着该药物在长期减肥疗效方面迈出了坚实一步。此次公布的临床试验结果无疑为Structure Therapeutics注入了强劲动力。在长达72周的观察窗口内,Aleniglipron不仅展现出持续且显著的减重效果,更凸显了其在肥胖症治疗领域的巨大潜力。值得注意的是,这一长期数据进一步巩固了Aleniglipron的安全性及耐受性轮廓。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPCR","BK4007","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129991235","title":"Structure Therapeutics候选药物Accg-2671展现约6天半衰期,未出现严重不良事件,1/2a期SAD试验中实现3.3%体重下降","url":"https://stock-news.laohu8.com/highlight/detail?id=1129991235","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129991235?lang=zh_cn&edition=fundamental","pubTime":"2026-09-08 20:03","pubTimestamp":1788868989,"startTime":"0","endTime":"0","summary":"Structure Therapeutics披露了其研发管线中备受关注的候选药物Accg-2671的最新临床数据。\n该公司表示,该药物在1/2a期单次递增剂量(SAD)临床试验中,展现出大约6天的半衰期特征。\n在安全性方面,研究过程中未观察到任何严重不良事件,表现令人鼓舞。\n此外,试验数据显示,受试者体重出现3.3%的下降幅度。这一系列积极结果或将为该药物后续的临床开发奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","GPCR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164454119","title":"Structure Therapeutics宣布ACCG-2671在12周MAD 1/2a期试验完成首批受试者给药,顶线数据预计2027年上半年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1164454119","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164454119?lang=zh_cn&edition=fundamental","pubTime":"2026-09-08 20:02","pubTimestamp":1788868934,"startTime":"0","endTime":"0","summary":"Structure Therapeutics日前披露,其候选药物ACCG-2671在为期12周的多剂量递增1/2a期临床试验中,已完成首批受试者给药。据悉,这项研究旨在评估ACCG-2671的安全性、耐受性及药代动力学特征,为后续更为深入的疗效验证奠定基础。公司方面表示,该试验的顶线数据预计将于2027年上半年对外公布。市场分析人士认为,ACCG-2671若能按期交出令人满意的数据,或将进一步巩固Structure Therapeutics在代谢及心血管疾病治疗领域的前沿地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4599","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173437492","title":"Structure Therapeutics公布口服小分子Amylin与GLP-1项目在慢性体重管理中的积极临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1173437492","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173437492?lang=zh_cn&edition=fundamental","pubTime":"2026-09-08 20:01","pubTimestamp":1788868877,"startTime":"0","endTime":"0","summary":"Structure Therapeutics对外披露,其在口服小分子Amylin及GLP-1项目中,收获了针对慢性体重管理的积极临床数据。此番成果,无疑为该公司在代谢性疾病治疗领域的布局注入了强劲动力。这些发现,不仅彰显了其研发管线的潜力,也或将为未来肥胖症治疗开辟新的路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GPCR","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164246465","title":"新闻稿:Septerna任命资深行业专家Rajiv Patni医学博士担任首席医疗官","url":"https://stock-news.laohu8.com/highlight/detail?id=1164246465","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164246465?lang=zh_cn&edition=fundamental","pubTime":"2026-08-25 20:05","pubTimestamp":1787659519,"startTime":"0","endTime":"0","summary":"南旧金山,2026年8月25日——Septerna, Inc.,一家致力于开创G蛋白偶联受体药物发现新纪元的临床阶段生物技术公司,今日宣布任命Rajiv Patni医学博士为首席医疗官。Patni博士是一位兼具医师与科学家身份的生物制药高管,拥有超过25年领导研发、监管及医学事务组织的丰富经验。“在我的职业生涯中,我多次在研发轨迹的转折点加入公司,而Septerna正处在这一阶段,”Patni博士表示。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPCR","SEPN","R","BK4232","BK4007","BK4599","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649939231","title":"数据简报-随着小型企业不断涌现,减肥药的上市竞争日益白热化","url":"https://stock-news.laohu8.com/highlight/detail?id=2649939231","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649939231?lang=zh_cn&edition=fundamental","pubTime":"2026-07-08 00:13","pubTimestamp":1783440834,"startTime":"0","endTime":"0","summary":"数据简报-随着小型企业不断涌现,减肥药的上市竞争日益白热化在第1、2和25段中补充了Kailera Therapeutics公司肥胖症药物的详细信息路透7月7日-凯莱拉制药的KLRA.O口服减肥药在中国开展的一项晚期临床试验中,帮助患者在第44周时减重 ,最高可达体重的10.9%。这两种药物目前均处于临床前试验阶段。华东制药中国华东制药公司的口服减肥候选药物HDM1002,在中国针对超重或肥胖受试者进行的一项早期研究中,使体重最多减少了6.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4T4391IA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266013472.USD","LU0432979614.USD","LLYZ","LU1629891620.HKD","LU1037948897.HKD","LU1969619763.USD","SG9999015945.SGD","IE00BJJMRZ35.SGD","BK1574","IE0002141913.USD","LU2471134879.HKD","IE00BJLML261.HKD","LU1035773651.USD","LU0823434583.USD","LU2750360641.GBP","LU0211331839.USD","LU0942090050.USD","LU0109394709.USD","LU1868836914.USD","LU1066053197.SGD","IYH","LU0861579265.USD","IE00B19Z3581.USD","LU1267930730.SGD","BK1589","LU2361045086.USD","AZNH","BK1161","LU0689472784.USD","LU1941712264.USD","VHT","BK4516","LU2213496289.HKD","IE0009355771.USD","LU2089284900.SGD","LU2328871848.SGD","LU0980610538.SGD","IE00B3T34201.USD","IE00BN29S564.USD","LU1093756168.USD","SG9999001176.USD","LU0203347892.USD","LU2023250330.USD","GB00BDT5M118.USD","LU0122379950.USD","IE00BLSP4452.SGD","LU2237443382.USD","LU1699723380.USD","VKTX","IE00B775H168.HKD","SG9999014559.SGD","LU2602419157.SGD","LU2087625088.SGD","FHLC","LU0058720904.USD","IE00BKVL7J92.USD","LU2433249047.HKD","IE00BLSP4239.USD","LU0786609619.USD","LU2236285917.USD","LU2168564495.EUR","LU0256863811.USD","IE00BFTCPJ56.SGD","LU2357305700.SGD","SG9999014898.SGD","LU1035775433.USD","LU1829250122.USD","LU2023250504.SGD","LU0106261372.USD","LU1868836757.USD","IE00BJJMRX11.SGD","LU0471298777.SGD","LU0882574139.USD","IE0002270589.USD","LU1323610961.USD","LU0208291251.USD","SG9999018865.SGD","IE00B1BXHZ80.USD","IXJ","LU2324357040.USD","LLYX","NVOH","BK1583","PJP","LU0098860793.USD","LU0823416689.USD","IE00BSNM7G36.USD","LU0158827948.USD","IE00BJT1NW94.SGD","LU0471298694.HKD","WDNA","LU2271345857.HKD","SGXZ31699556.SGD","LU1023059063.AUD","LU1988902786.USD","LU1712237335.SGD","SGXZ51526630.SGD","LU0943347566.SGD","IE00BKPKM429.USD","BK4007","LU0203345920.USD","LU0868494617.USD","LU0029864427.USD","LU1064131342.USD","LU1061106388.HKD","LU1934455277.USD","LU0320765646.SGD","SG9999014542.SGD","SG9999013999.USD","JDOC","LU0070302665.USD","LU1232071149.USD","LU2112291526.USD","LU0455707207.USD","BK1515","BK4581","LU1720051108.HKD","LU2462157665.USD","LU1551013342.USD","LU2097828631.EUR","LU1267930573.SGD","SG9999015986.USD","LU0456855351.SGD","LU0006306889.USD","LU0320765489.SGD","OZEM","LU0672654240.SGD","LU0820562030.AUD","LU2491050071.SGD","LU1934455863.HKD","LU0256863902.USD","LU0385154629.USD","LU1066051225.USD","LU0238689110.USD","LU2168564065.EUR","IE00BK4W5M84.HKD","LU2237438978.USD","LU2471134952.CNY","LU2168564149.EUR","BK4592","LU2097828557.USD","LU2461242641.AUD","LU0965509101.SGD","LU2468319806.SGD","BK4139","LU2491050154.USD","LU1868837136.USD","LU0203201768.USD","LU0109391861.USD","IE00BZ1G4Q59.USD","LU1917777945.USD","LU2756315318.SGD","BK1191","PPH","LU0323591593.USD","LU2237443622.USD","LU1989772923.USD","HK0000165453.HKD","SG9999017495.SGD","LU0306807586.USD","LU2750360997.AUD","LU1127390331.HKD","IE00B19Z3B42.SGD","LU1066051811.HKD","THNR","BK4533","SG9999002232.USD","LU0310800379.SGD","MEDX","LU0203202063.USD","SG9999015952.SGD","LU0985320562.USD","LU1983299246.USD","IE00BN8TJ469.HKD","LU0170899867.USD","LU0225771236.USD","LU1894683348.USD","LU0097036916.USD","LU2108987350.USD","BK4599","LU0345770308.USD","SG9999015341.SGD","LU0130102774.USD","BK4559","LU0683600562.USD","SG9999002224.SGD","LLY","LU0965509283.SGD","IE00BBT3K403.USD","LU1116320901.HKD","LU0079474960.USD","LU0225284248.USD","LU0316494557.USD","LU1291159041.SGD","LU2488822045.USD","LU0154236417.USD","SG9999001176.SGD","LU2491049909.HKD","LLII","BK4585","BMED","LU2264538146.SGD","LU2756315664.SGD","GPCR","LU0128525929.USD","LU0094547139.USD","IE0004445015.USD","LU0823434740.USD","LU0466842654.USD","LU0345770993.USD","LU0061475181.USD","LU1069347547.HKD","IE00B4R5TH58.HKD","GDOC","LU0114720955.EUR","SG9999003800.SGD","KURE","LU2063271972.USD","LU2023251221.USD","LU0985481810.HKD","LU0158827781.USD","SG9999014575.USD","LU2097828474.EUR","LU2125154935.USD","LU1093756325.SGD","LU0354030438.USD","LU2360032135.SGD","LU0889565916.HKD","IE00B1XK9C88.USD","LU1201861249.SGD","SG9999014567.USD","LU2746668461.USD","LU2596442595.SGD","LU2125154778.USD","LU1571399168.USD","LU1585245621.USD","NVOX","LU1720051017.SGD","IE00BK4W5L77.USD","LU0417517546.SGD","IE00B4JS1V06.HKD","SG9999015978.USD","LU2552382215.SGD","LU2746668974.SGD","LU0787776722.HKD","IE000M9KFDE8.USD","LU2237443549.SGD","LU0965509010.AUD","PFE","LU2417539215.USD","LU0502904849.HKD","LU0868494708.USD","LU1929549753.HKD","LU2471134796.USD","KLRA","LU1989771016.USD","LU0964807845.USD","LU1623119135.USD","LU0306806265.USD","LU1941712348.USD","LU2361044865.SGD","IE00BFSS7M15.SGD","LU0265550946.USD","CURE","01672","LU1804176565.USD","CANC","AZN","NVO","LU2265009873.SGD","LU2168563687.JPY","SG9999015358.SGD","LU0354030511.USD","IE00BJJMRY28.SGD","SG9999014880.SGD","LU2097828714.EUR","IE00BWXC8680.SGD","LU0320765059.SGD","ILDR","LU0640476718.USD","IE00B7KXQ091.USD","01801","LU1116320737.USD","LU1894683264.USD","SGXZ57979304.SGD","LU0353189763.USD","LU0096364046.USD","LU0133085943.USD","SG9999018857.SGD","LU1162221912.USD","AGNG","LU0289739699.SGD","LU1974910355.USD","LU1366192091.USD","ELIL","ELIS","LU2211815571.USD","LU0321505868.SGD","LU1934455194.USD","LU2361044949.HKD","LU2360106947.USD","LU2106854487.HKD","LU2028103732.USD","LU0320765992.SGD","LU1868836591.USD","LU2456880835.USD","IE00B2B36J28.USD","IE0005OL40V9.USD","BK4568","LU1814569148.SGD","LU2237443465.HKD","LU0234572021.USD","BK4588","BK4532","LU1066051498.USD","HRTS","LU0708994859.HKD","LU0198837287.USD","LU1430594728.SGD","LU0130517989.USD","LU2552382132.HKD","IE00BFSS8Q28.SGD","LU0882574055.USD","LU1057294990.SGD","LU0477156953.USD","LU2237443978.SGD","LU2896262040.SGD","LU1923622614.USD","IE0001KFT4U8.USD","LU2023250843.SGD","LU2089283258.USD","LU1037948541.HKD","LU2111349929.HKD","SG9999001440.SGD","LU2552382058.USD","LU0265550359.USD","LU0321505439.SGD","LU0225283273.USD","LU2097828805.USD","MEDI","FTXH","LU0820561909.HKD","LU2242644610.SGD","LU0820561818.USD","SG9999011175.SGD","LU1883839398.USD","LU0708995401.HKD","MRK","BK4534","LU0648001328.SGD","LU2089984988.USD","IE0004445239.USD","RXL","LU2168564222.USD","IE00BKDWB100.SGD","SGXZ99366536.SGD","LU2237443895.HKD","LU1551013425.SGD","LU2471134523.USD","LU0353189680.USD","LU2125909593.SGD","PAWZ","SG9999014914.USD","IHE","LU1868837300.USD","LU0859254822.USD","LU2357627491.SGD","LU0210536198.USD","LU2125909247.SGD","SGXZ81514606.USD","XLV","BK4550","LU1069344957.HKD","LU1145028129.USD","LU0965508806.USD","LU1548497426.USD","LU1280957306.USD","LU1989772840.SGD","SG9999014906.USD","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642495621","title":"晶泰控股(02228)与国际知名药企达成超4亿美元AI药物发现战略合作 攻坚GPCR靶点口服新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2642495621","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642495621?lang=zh_cn&edition=fundamental","pubTime":"2026-06-09 22:30","pubTimestamp":1781015452,"startTime":"0","endTime":"0","summary":"智通财经APP讯,晶泰控股 发布公告,公司董事会欣然宣布与一家国际知名生物制药公司达成战略合作。根据协议,合作方将向晶泰支付首付款并承担所有的早期研发费用,晶泰还将获得临床前、临床及商业化里程碑付款,以及未来的销售分成,项目潜在总金额超4亿美元。进入全面合作阶段后,晶泰将全面启用其结构理性药物设计平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452260.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CHAT","GPCR","ARTY","BK1141","BK4007","AGIX","BK1617","AIPO","BK4599","02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641112886","title":"Structure实验性减肥药未显示肝损伤迹象","url":"https://stock-news.laohu8.com/highlight/detail?id=2641112886","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641112886?lang=zh_cn&edition=fundamental","pubTime":"2026-06-06 05:15","pubTimestamp":1780694132,"startTime":"0","endTime":"0","summary":"Structure实验性减肥药未显示肝损伤迹象Sriparna Roy路透6月5日 - Structure Therapeutics周五表示,其试验性GLP-1减肥药未显示任何药物性肝损伤的迹象,且患者即使在服用较低剂量时仍持续减重。Structure公司今年3月曾报告,在一项中期试验中,服用该公司每日一次药片的患者,在44周后,180毫克剂量组的体重较安慰剂组最多减轻了39磅。Structure公司表示,对研究期间每位患者用药情况的回顾显示,虽然部分患者需要中断或减少剂量,但一旦恢复治疗或再次增加剂量,呕吐症状很少复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nL4T42D1NS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","GPCR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180747442","title":"Structure Therapeutics宣布,Aleniglipron在2B期试验中显示出长达36周以上最高达16.2%的减重效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1180747442","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180747442?lang=zh_cn&edition=fundamental","pubTime":"2026-06-06 04:18","pubTimestamp":1780690711,"startTime":"0","endTime":"0","summary":"Structure Therapeutics Inc. 近日公布了其口服GLP-1受体激动剂Aleniglipron在2B期临床试验中的积极顶线结果。数据显示,在为期36周的治疗期内,接受Aleniglipron治疗的患者实现了显著的体重减轻,最高减重幅度达到16.2%。这项随机、双盲、安慰剂对照的试验评估了不同剂量Aleniglipron在肥胖或超重成人中的疗效与安全性。除了显著的减重数据,Aleniglipron在改善血糖控制等次要终点上也表现出积极趋势。这一积极数据进一步验证了Aleniglipron作为潜在重磅口服减肥疗法的前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4007","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178081119","title":"Structure Therapeutics旗下阿伦利普隆展现良好耐受性,停药率仅为10.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1178081119","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178081119?lang=zh_cn&edition=fundamental","pubTime":"2026-06-06 04:18","pubTimestamp":1780690707,"startTime":"0","endTime":"0","summary":"Structure Therapeutics公司宣布,其研发的药物阿伦利普隆在临床试验中表现出良好的耐受性特征,患者停药率低至10.4%。这一数据突显了该药物在治疗过程中的可接受性与安全性,为其进一步的临床开发与应用奠定了积极基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPCR","BK4599","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154055283","title":"Structure Therapeutics修订并重述与Leerink Partners及Cantor Fitzgerald的销售协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1154055283","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154055283?lang=zh_cn&edition=fundamental","pubTime":"2026-05-08 05:17","pubTimestamp":1778188666,"startTime":"0","endTime":"0","summary":"生物制药公司Structure Therapeutics Inc于2026年5月7日向美国证券交易委员会提交文件,宣布与Leerink Partners LLC及Cantor Fitzgerald & Co.共同签署经修订与重述的股权分销协议。该协议旨在优化公司未来通过\"at-the-market\"股权发行计划进行融资的运作框架。此次协议修订涉及分销条款、佣金结构及结算流程等核心商业条款的更新,标志着Structure Therapeutics与两家顶尖医疗健康领域投行深化战略合作的里程碑。通过完善销售协议机制,公司将进一步增强资本运作灵活性,为管线药物研发提供可持续的资金支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4599","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160867102","title":"Structure Therapeutics将ATM增发规模扩大1.5亿美元 总额达4亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1160867102","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160867102?lang=zh_cn&edition=fundamental","pubTime":"2026-05-08 05:17","pubTimestamp":1778188634,"startTime":"0","endTime":"0","summary":"生物医药公司Structure Therapeutics Inc(股票代码:GPCR)近日向美国证券交易委员会提交文件,宣布将其ATM(按市价发行)股票增发计划规模扩大1.5亿美元。此次调整后,该公司的ATM增发总规模将达到4亿美元。\nATM增发机制允许上市公司在特定时期内,根据市场情况灵活地向公众发售新股。此次规模扩充将为Structure Therapeutics提供更充足的资金流动性,支持其临床阶段药物研发管线的推进。该公司专注于开发针对代谢性疾病的口服小分子疗法,此次融资安排彰显了其持续优化资本结构的战略布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4599","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630391708","title":"埃诺格鲁肽注射液全国首批处方落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2630391708","media":"经济参考网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630391708?lang=zh_cn&edition=fundamental","pubTime":"2026-04-27 20:50","pubTimestamp":1777294212,"startTime":"0","endTime":"0","summary":"4月27日,新一代cAMP偏向型GLP-1受体激动剂埃诺格鲁肽注射液(先维盈)在北京大学人民医院与复旦大学附属中山医院同步开出全国首批处方,标志着这款创新体重管理疗法正式在中国迈入临床应用阶段。据悉,GLP-1受体激动剂的创新研发有两条路线。传统路线是以GLP-1为核心靶点叠加其他作用靶点,如GIP、GCG等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604273720616957.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604273720616957.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["GPCR","BK4599","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115849765","title":"Structure Therapeutics任命Matthew Lang为首席运营官兼总法律顾问","url":"https://stock-news.laohu8.com/highlight/detail?id=1115849765","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115849765?lang=zh_cn&edition=fundamental","pubTime":"2026-04-15 04:07","pubTimestamp":1776197275,"startTime":"0","endTime":"0","summary":"旧金山,2026年4月14日——临床阶段全球生物制药公司Structure Therapeutics Inc.今日宣布,任命Matthew Lang, J.D. 为公司首席运营官兼总法律顾问。Lang先生在加入Structure Therapeutics时,已在全球生物制药机构拥有超过十五年的高管领导经验,其深厚专长涵盖法律、企业战略、合规、风险管理和业务发展等多个领域。Structure Therapeutics首席执行官Raymond Stevens博士表示:\"Matt是一位经验丰富的领导者,在引导组织实现增长和转型方面拥有卓越的业绩记录。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4139","R","BK4539","BK4232","GPCR","LENZ","BK4599","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}]}}